{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T21:36:30Z","timestamp":1788471390853,"version":"build-2803163510"},"reference-count":14,"publisher":"Informa UK Limited","issue":"6","license":[{"start":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T00:00:00Z","timestamp":1746662400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"name":"The Global Antibiotic R&D Partnership (GARDP) and Innoviva Specialty Therapeutics, Inc"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Anti-infective Therapy"],"published-print":{"date-parts":[[2026,6,3]]},"DOI":"10.1080\/14787210.2025.2502799","type":"journal-article","created":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T09:53:24Z","timestamp":1746438804000},"page":"647-648","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["Letter to the editor regarding \u201cAlternative drugs for the treatment of gonococcal infections: old and new\u201d\n                    <i>Expert Review of Anti-infective Therapy<\/i>\n                    . 2024. 22(9):753\u2013759"],"prefix":"10.1080","volume":"24","author":[{"given":"Alison","family":"Luckey","sequence":"first","affiliation":[{"name":"Global Antibiotic R&D Partnership","place":["Geneva, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Altarac","sequence":"additional","affiliation":[{"name":"Entasis Therapeutics Inc., an affiliate of Innoviva Specialty Therapeutics, Inc","place":["Waltham, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7827-794X","authenticated-orcid":false,"given":"Sarah M.","family":"McLeod","sequence":"additional","affiliation":[{"name":"Entasis Therapeutics Inc., an affiliate of Innoviva Specialty Therapeutics, Inc","place":["Waltham, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,5,8]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1080\/14787210.2024.2401560"},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsinfecdis.0c00021"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep11827"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M115.663534"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.04456-14"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2015.01377"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.682135"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24021634"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkab024"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiad027"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00863-20"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkac366"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1706988"},{"key":"e_1_3_3_15_1","unstructured":"Luckey A Broadhurst H Daram P et al. Zoliflodacin is non-inferior to a combination of ceftriaxone and azithromycin for treatment of uncomplicated urogenital gonorrhoea: results of a large global phase 3 trial. Oral presentation No. OS246. Presented at ESCMID global 2024: congress of the European society of clinical microbiology and infectious diseases. Barcelona Spain. 2024 Apr 27\u201330. Available from: https:\/\/gardp.org\/wp-content\/uploads\/2024\/04\/Zoli001-Topline-ECCMID2024_final_V1.0_23Apr2024_.pdf; https:\/\/innovivaspecialtytherapeutics.com\/wp-content\/uploads\/2024\/12\/Zoli001-Topline-ECCMID2024_FINAL_V1.0_23Apr2024.pdf"}],"container-title":["Expert Review of Anti-infective Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14787210.2025.2502799","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/14787210.2025.2502799","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14787210.2025.2502799","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T05:29:21Z","timestamp":1781846961000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14787210.2025.2502799"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,8]]},"references-count":14,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6,3]]}},"alternative-id":["10.1080\/14787210.2025.2502799"],"URL":"https:\/\/doi.org\/10.1080\/14787210.2025.2502799","relation":{},"ISSN":["1478-7210","1744-8336"],"issn-type":[{"value":"1478-7210","type":"print"},{"value":"1744-8336","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,8]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierz20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierz20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-05-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}